News
Remdesivir showing success in combating COVID-19
April 30, 2020
Early results of a COVID-19 treatment study being conducted in San Antonio shows a faster recovery time and fewer deaths for patients.
Scientists research a solution to the metabolic crisis
April 27, 2020
“Millions of people consume too much food, while millions of others are in poverty and subsist on too little food. We are studying what happens at the molecular level in both situations with a goal of developing a drug to intervene,” said Dr. Madesh Muniswamy.
Researchers aim at the heart of COVID-19 cardiac damage
April 20, 2020
To understand and prevent COVID-19-induced heart disease, researchers will follow recovered patients.
A breakthrough in the way blood is stored
April 13, 2020
UT Health San Antonio played a major research role in the FDA’s recent approval of a new process that nearly triples the five-day shelf life of blood platelets, commonly used for treating trauma patients.
Researchers study antibodies against coronavirus
April 1, 2020
As laboratories across the country rush to find answers for the novel coronavirus, UT Health San Antonio is bringing a unique combination of expertise to bear on the crisis.
UT Health San Antonio leads COVID-19 treatment study
March 30, 2020
UT Health San Antonio and University Health System physicians are among the first in the nation to test an investigational drug.
Long-lasting treatment drug could slow the opioid crisis
March 10, 2020
Researchers are developing an anti-opioid drug to protect against overdose for weeks or longer.
CPRIT awards millions for San Antonio cancer research
February 24, 2020
Grants will advance the work of the Center for Innovative Drug Discovery, a research center offered jointly by UT Health San Antonio and UTSA.
Rivard Report: SA team aiming for improved sepsis therapies receives grant
February 12, 2020
A team of researchers was awarded a grant to study sepsis, which contributes to a third of all hospital deaths in the United States.
San Antonio Partnership for Precision Therapeutics awards inaugural research funding
February 11, 2020
Leaders of the newly-established San Antonio Partnership for Precision Therapeutics (SA PPT) have awarded the partnership’s first research grant. The team, led by Principal Investigator Dr. Madesh Muniswamy of UT Health San Antonio, is studying the cause, prevention and treatment of multi-organ failure during sepsis.